ID: ALA2393334

Max Phase: Preclinical

Molecular Formula: C10H11N3

Molecular Weight: 173.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNc1ccnc2cc(N)ccc12

Standard InChI:  InChI=1S/C10H11N3/c1-12-9-4-5-13-10-6-7(11)2-3-8(9)10/h2-6H,11H2,1H3,(H,12,13)

Standard InChI Key:  KMKQEQOUJKKBGT-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 173.22Molecular Weight (Monoisotopic): 173.0953AlogP: 1.86#Rotatable Bonds: 1
Polar Surface Area: 50.94Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.50CX LogP: 0.77CX LogD: -0.50
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.65Np Likeness Score: -0.67

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source